Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Mbio|January 25, 2022
Assessment of Plasmodium falciparum Artemisinin Resistance Independent of <i>kelch13</i> Polymorphisms and with Escalating Malaria in BangladeshMaisha Khair Nima, Angana Mukherjee, Saiful Arefeen Sazed, et al.
American Journal of Hematology|February 3, 2015
Evidence gaps in the management of sickle cell disease: A summary of needed researchWilliam J Savage, George R Buchanan, Barbara P Yawn, et al.
Blood Advances|January 17, 2025
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trialRosa M Nieves, Teresa Latham, Nicolle Marte, et al.
Pediatric Blood & Cancer|September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study designBruce W Thompson, Scott T Miller, Zora R Rogers, et al.
JAMA|September 10, 2014
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel membersBarbara P Yawn, George R Buchanan, Araba N Afenyi-Annan, et al.
Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
American Journal of Hematology|December 1, 2015
Effects of hydroxyurea treatment for patients with hemoglobin SC diseaseLori Luchtman-Jones, Sara Pressel, Lee Hilliard, et al.
The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
NEJM Evidence|December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC DiseaseYvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Blood Advances|March 11, 2026
Newborn Screening Results for Sickle Cell Disease from the ASH Consortium on Newborn Screening in Africa (CONSA)Bernard Awuonda, Charles Kiyaga, Lulu Fred Chirande, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Mbio|January 25, 2022
Assessment of Plasmodium falciparum Artemisinin Resistance Independent of <i>kelch13</i> Polymorphisms and with Escalating Malaria in BangladeshMaisha Khair Nima, Angana Mukherjee, Saiful Arefeen Sazed, et al.
American Journal of Hematology|February 3, 2015
Evidence gaps in the management of sickle cell disease: A summary of needed researchWilliam J Savage, George R Buchanan, Barbara P Yawn, et al.
Blood Advances|January 17, 2025
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trialRosa M Nieves, Teresa Latham, Nicolle Marte, et al.
Pediatric Blood & Cancer|September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study designBruce W Thompson, Scott T Miller, Zora R Rogers, et al.
JAMA|September 10, 2014
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel membersBarbara P Yawn, George R Buchanan, Araba N Afenyi-Annan, et al.
Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
American Journal of Hematology|December 1, 2015
Effects of hydroxyurea treatment for patients with hemoglobin SC diseaseLori Luchtman-Jones, Sara Pressel, Lee Hilliard, et al.
The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
NEJM Evidence|December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC DiseaseYvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Blood Advances|March 11, 2026
Newborn Screening Results for Sickle Cell Disease from the ASH Consortium on Newborn Screening in Africa (CONSA)Bernard Awuonda, Charles Kiyaga, Lulu Fred Chirande, et al.
Pageof 27